NYGIL MATTHEWS: Open Payments
NPI 1215448501 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 40 payments from 10 companies in 2025. Trend: 2023 $699 · 2024 $788 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $311 |
| Merz Pharmaceuticals, LLC | 7 | $186 |
| ACADIA Pharmaceuticals Inc | 5 | $110 |
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| Medtronic, Inc. | 2 | $62 |
| Amneal Pharmaceuticals LLC | 4 | $61 |
| UCB, Inc. | 2 | $30 |
| Biogen, Inc. | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Impel Pharmaceuticals LLC | 1 | $15 |
Products named: VYALEV, Xeomin, NUPLAZID, BOTOX, INBRIJA, AUSTEDO XR, CREXONT, PERCEPT PC BRAINSENSE.
Industry payments across TX — which companies pay providers there.
